Skip to content

Clinical trials

Pulmonary Arterial Hypertension trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Country / region: Austria Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20051
20064
20071
20086
20094
20103
20113
20121
20134
20143
20162
20173
20195
20201
20213
20222
20233
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Terminated9
Active, not recruiting2
Enrolling by invitation2
Recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion15
United Therapeutics9
Bayer5
Medical University of Graz4
AOP Orphan Pharmaceuticals AG3
Novartis Pharmaceuticals3
Bial - Portela C S.A.2
Insmed Incorporated2
Regina Steringer-Mascherbauer2
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension54
Hypertension, Pulmonary17
Hypertension3
Cardiovascular Diseases2
Connective Tissue Diseases2
Eisenmenger Complex2
Familial Primary Pulmonary Hypertension2
Lung Diseases2
Respiratory Tract Diseases2
Scleroderma, Systemic2

Trials

Showing 26 to 50 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.